SCHEMBL23043546

SCHEMBL23043546

C#CCNc1nc2ccccc2n1-c1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.51
GRIA1 P42261 1/20 0.46
CACNG8 Q8WXS5 1/20 0.46
CACNG2 Q9Y698 1/20 0.46
MCHR1 Q99705 6/20 0.46
PIK3CD O00329 1/20 0.43
PIK3CA P42336 1/20 0.43
PIK3CB P42338 1/20 0.43
MTOR P42345 1/20 0.43
PIK3CG P48736 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SCN9A Q15858 4/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5811766 0.77 RAB9A (0.62) TSHRNPC1RAB9ATP53POLB
SCHEMBL29738135 0.75 POLB (0.56) GRIA1CACNG8CACNG2MCHR1NPC1
SCHEMBL22507416 0.72 MAPK1 (0.74) TSHRGRIA1CACNG8CACNG2PIK3CD
SCHEMBL16940824 0.72 TP53 (0.50) TSHRMCHR1PIK3CAMTORNPC1
SCHEMBL10819080 0.72 RAB9A (0.61) TSHRGRIA1CACNG8CACNG2MCHR1
SCHEMBL23043553 0.69 RAB9A (0.49) TSHRGRIA1CACNG8CACNG2MCHR1
SCHEMBL29738197 0.69 GRIA1 (0.44) TSHRGRIA1CACNG8CACNG2MCHR1
SCHEMBL5089620 0.68 RAB9A (0.70) TSHRNPC1RAB9ATP53GAA
SCHEMBL12130054 0.67 GRIA1 (0.74) GRIA1CACNG8CACNG2SMN1; SMN2SCN9A
SCHEMBL10543627 0.67 NPC1 (0.60) GRIA1CACNG8CACNG2MCHR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021041536-A1 BENZIMIDAZOLE AND HYDROGENATED CARBAZOLE DERIVATIVES AS GPX4 INHIBITORS Ferro Therapeutics, Inc. (US) 2021-03-04 WO disclosed